Citius Oncology (CTOR) Common Equity (2021 - 2026)
Citius Oncology's Common Equity was $40.38 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 24.7% from $32.4 million a year earlier and up 14.5% from the prior quarter.
Powered by 
Analysis
Citius Oncology (CTOR) Common Equity (2021 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Common Equity at Citius Oncology came in at $44.87 million, down 2.8% from FY2024.
- In earlier fiscal years, Common Equity was $46.14 million in FY2024, $22.73 million in FY2023, $345,508 in FY2022 and -$10,113 in FY2021.
- Quarterly Common Equity has moved between -$10,113 (fiscal Q4 2021) and $58.41 million (fiscal Q1 2026) over five years.
- Compared with a year earlier, Common Equity was higher in two of the last four quarters, with growth averaging 15.6%.
- Per Business Quant data, CTOR's Common Equity in the three fiscal quarters before Q3 2026 was $35.27 million (Q2 2026), $58.41 million (Q1 2026) and $44.87 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Citius Oncology | 60.42 Mn | 30.00 Mn | 1.00 Mn | 40.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.38 Mn |
| Mar 31, 2026 | 35.27 Mn |
| Dec 31, 2025 | 58.41 Mn |
| Sep 30, 2025 | 44.87 Mn |
| Jun 30, 2025 | 32.40 Mn |
| Mar 31, 2025 | 35.64 Mn |
| Dec 31, 2024 | 41.29 Mn |
| Sep 30, 2024 | 46.14 Mn |
| Jun 30, 2024 | 17.03 Mn |
| Mar 31, 2024 | 19.85 Mn |
| Dec 31, 2023 | 22.73 Mn |
| Sep 30, 2023 | 25.54 Mn |
| Jun 30, 2023 | -1,968.00 |
| Mar 31, 2023 | 197,586.00 |
| Dec 31, 2022 | 345,508.00 |
| Sep 30, 2022 | 36.27 Mn |
| Mar 31, 2022 | -10,113.00 |
| Dec 31, 2021 | -10,113.00 |
API Access
Citius Oncology Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CTOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CTOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CTOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();